Consumer Feedback Needed

Pharmac is calling for submissions on a proposal to fund a biosimilar brand of adalimumab (Amgevita) which means that All new patients will start use of Amgevita from 1 February 2022 All existing Humira patients whose prescribers think can be changed would need to...

Translate »